Brian Johnson - Novan Chief Commercial Officer
| NOVNDelisted Stock | USD 0.13 0.00 0.00% |
Executive
Mr. Brian Johnson is a Chief Commercial Officer of the Company. He has served as our Chief Commercial Officer since September 2015. Prior to joining Novan, Mr. Johnson worked at Galderma Laboratories, L.P. from 2003 to 2014, and most recently served as Vice President of Prescription Marketing and Chief Digital Officer. He also currently serves as principal and sole advisor of Two Hearts Group, LLC, a consulting company focused on drug development companies. since 2015.
| Age | 57 |
| Tenure | 9 years |
| Phone | 919 485 8080 |
| Web | https://www.novan.com |
Novan Management Efficiency
The company has return on total asset (ROA) of (0.2584) % which means that it has lost $0.2584 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (20.9889) %, meaning that it created substantial loss on money invested by shareholders. Novan's management efficiency ratios could be used to measure how well Novan manages its routine affairs as well as how well it operates its assets and liabilities.Novan Inc currently holds 3.93 M in liabilities with Debt to Equity (D/E) ratio of 4.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Novan Inc has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Novan's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Naomi Eichenbaum | Travere Therapeutics | N/A | |
| Farrell PharmD | Trevi Therapeutics | N/A | |
| Nivi Nehra | Travere Therapeutics | N/A | |
| Sandra Vedrick | Revelation Biosciences | N/A | |
| Carol MBA | Jaguar Animal Health | 60 | |
| Vineeta Belanger | Lyra Therapeutics | N/A | |
| Danine Summers | Trevi Therapeutics | 66 | |
| Andrew Taubman | Adial Pharmaceuticals | N/A | |
| Gregory MD | Tonix Pharmaceuticals Holding | 58 | |
| Felipe Duran | Ibio Inc | 45 | |
| Adrienne Kemp | Tarsus Pharmaceuticals | N/A | |
| Robert Richard | Lyra Therapeutics | 66 | |
| Ryker Willie | Palisade Bio | N/A | |
| MS MD | Aditxt Inc | N/A | |
| Ray Knox | Lyra Therapeutics | N/A | |
| Robert MD | Lyra Therapeutics | N/A | |
| Kristi Sarno | Ibio Inc | N/A | |
| MD JD | Tarsus Pharmaceuticals | 46 | |
| Matthew MBA | Tarsus Pharmaceuticals | 46 | |
| Justine OMalley | Protara Therapeutics | N/A | |
| Christopher CFA | Travere Therapeutics | 39 | |
Management Performance
| Return On Equity | -20.99 | |||
| Return On Asset | -0.26 |
Novan Inc Leadership Team
Elected by the shareholders, the Novan's board of directors comprises two types of representatives: Novan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novan. The board's role is to monitor Novan's management team and ensure that shareholders' interests are well served. Novan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Paula MPH, CEO Pres | ||
| John Donofrio, COO VP | ||
| Carri Geer, Senior Vice President and CTO | ||
| JD BS, VP RD | ||
| Brian Johnson, Chief Commercial Officer | ||
| Andrew Novak, Vice President Chief Accounting Officer and Principal Accounting Officer | ||
| MBA MD, Chief Officer | ||
| Cole Ikkala, Communications Relations | ||
| John CPA, CFO Sec |
Novan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -20.99 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (1.29) % | |||
| Operating Margin | (1.59) % | |||
| Current Valuation | 27.74 M | |||
| Shares Outstanding | 28.02 M | |||
| Shares Owned By Insiders | 0.86 % | |||
| Shares Owned By Institutions | 14.93 % | |||
| Number Of Shares Shorted | 462.95 K | |||
| Price To Earning | (1.49) X |
Pair Trading with Novan
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novan position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novan will appreciate offsetting losses from the drop in the long position's value.Moving together with Novan Stock
| 0.8 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.78 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.74 | BKRKF | PT Bank Rakyat | PairCorr |
Moving against Novan Stock
| 0.88 | WMT | Walmart Aggressive Push | PairCorr |
| 0.88 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.87 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.86 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.82 | T | ATT Inc Aggressive Push | PairCorr |
The ability to find closely correlated positions to Novan could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novan when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novan - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novan Inc to buy it.
The correlation of Novan is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Novan moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Novan Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Novan can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Novan Stock
If you are still planning to invest in Novan Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novan's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |